Healthcare NSE: SUNPHARMA

Sun Pharmaceutical Financial Statements, P/E Ratio & ROE Valuation

Sun Pharmaceutical (SUNPHARMA) — Drug Manufacturers - Specialty & Generic

₹1,951.00 INR

▲ ₹11.00 (+0.57%)

Overview Share Price Financials & P/E Dividends Shareholding Peer Comparison

Sun Pharmaceutical Financial Statements & Valuation Multiples

✨ Financials & Valuation Analysis

Sun Pharmaceutical commands a premium valuation with a P/E of 38.664288, supported by high market dominance and profitability expectations.

P/E Ratio (TTM) 38.664288

Forward P/E 29.666182

Price-to-Book (P/B) 5.601413

Return on Equity (ROE) N/A

Profit Margin 20.19%

Operating Margin 23.25%

EPS (TTM) ₹50.44

Enterprise Value ₹4.40 Lakh Cr

Financial Health & Profitability Breakdown for Sun Pharmaceutical

A comprehensive review of Sun Pharmaceutical reveals an ROE of N/A and operating profitability margins of 23.25%. Sun Pharmaceutical maintains high capital efficiency with an ROE of null% and operating margins of 23.25%, demonstrating robust cash generation capabilities.

Evaluating valuation metrics, Sun Pharmaceutical maintains a Price-to-Earnings ratio of 38.664288 and a Price-to-Book multiple of 5.601413. These valuation metrics, combined with an Enterprise Value of ₹4.40 Lakh Cr, provide essential indicators for fundamentally driven stock selection in India's Healthcare sector.

Frequently Asked Questions

What is Sun Pharmaceutical P/E ratio and Price-to-Book (P/B) ratio?

Sun Pharmaceutical trades at a trailing P/E of 38.664288, a Forward P/E of 29.666182, and a P/B ratio of 5.601413.

What is Sun Pharmaceutical Return on Equity (ROE)?

Sun Pharmaceutical reports a Return on Equity (ROE) of N/A, reflecting shareholder capital efficiency.

What are Sun Pharmaceutical profit margin and operating margin?

Sun Pharmaceutical maintains a net profit margin of 20.19% and an operating margin of 23.25%.

What is Sun Pharmaceutical Enterprise Value and EBITDA multiplier?

Sun Pharmaceutical has an Enterprise Value of ₹4.40 Lakh Cr and reported earnings per share (TTM EPS) of ₹50.44.

Explore Similar Healthcare Stocks

Explore Categories:

Technology Stocks Banking Stocks Nifty 50 Stocks Dividend Stocks Large Cap Stocks